Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas - an immunohistochemical study

被引:41
作者
Habberstad, Andreas H. [1 ]
Gulati, Sasha [1 ,2 ]
Torp, Sverre H. [1 ,3 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
[2] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway
[3] St Olavs Univ Hosp, Dept Pathol & Med Genet, Trondheim, Norway
关键词
HISTONE H3; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; NUCLEAR; TUMORS; GRADE; INDEX; KI-67; PHOSPHORYLATION; APOPTOSIS;
D O I
10.1186/1746-1596-6-43
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Histological malignancy grading of astrocytomas can be challenging despite criteria given by the World Health Organisation (WHO). Grading is fundamental for optimal prognostication and treatment, and additional biomarkers are needed to support the histopathological diagnosis. Estimation of proliferative activity has gained much enthusiasm, and the present study was designed to evaluate and compare novel immunohistochemical proliferative markers in human anaplastic astrocytomas. Methods: Proliferative activity was determined in twenty-seven cases with antibodies reactive against the Ki-67 antigen, mitosin, survivin, pHH3, and DNA topoisomerase II alpha, and they were mutually compared as well as related to mitotic activity. Results: The markers correlated well with each other, but poorly with mitoses, probably because of small and squeezed tumour samples, in which identification of mitoses can be difficult. Positive association to overall survival was observed as well. Conclusions: Our data show that these markers may assist significantly in the evaluation of proliferative activity in anaplastic astrocytomas and even have prognostic value.
引用
收藏
页数:8
相关论文
共 32 条
[21]   The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate [J].
McLaughlin, N ;
Annabi, B ;
Bouzeghrane, M ;
Temme, A ;
Bahary, JP ;
Moumdjian, R ;
Béliveau, R .
BRAIN RESEARCH, 2006, 1071 (01) :1-9
[22]   The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms [J].
Prayson, RA .
ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (03) :144-148
[23]   Cell proliferation and tumors of the central nervous system part 1: Evaluation of mitotic activity [J].
Prayson, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (06) :501-509
[24]   No prognostic impact of survivin expression in glioblastoma [J].
Preusser, M ;
Gelpi, E ;
Matej, R ;
Marosi, C ;
Dieckmann, K ;
Rössler, K ;
Budka, H ;
Hainfellner, JA .
ACTA NEUROPATHOLOGICA, 2005, 109 (05) :534-538
[25]   The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria [J].
Ribalta, T ;
McCutcheon, AE ;
Aldape, KD ;
Bruner, JM ;
Fuller, GN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) :1532-1536
[26]   Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker [J].
Saito, Taiichi ;
Arifin, Muhamad Thohar ;
Hama, Seiji ;
Kajiwara, Yoshinori ;
Sugiyama, Kazuhiko ;
Yamasaki, Fumiyuki ;
Hidaka, Toshikazu ;
Arita, Kazunori ;
Kurisu, Kaoru .
JOURNAL OF NEURO-ONCOLOGY, 2007, 82 (02) :193-198
[27]   Nuclear survivin expression predicts poorer prognosis in glioblastoma [J].
Shirai, Katsuyuki ;
Suzuki, Yoshiyuki ;
Oka, Kuniyuki ;
Noda, Shin-ei ;
Katoh, Hiroyuki ;
Suzuki, Yoshihiko ;
Itoh, Jun ;
Itoh, Hideaki ;
Ishiuchi, Shogo ;
Sakurai, Hideyuki ;
Hasegawa, Masatoshi ;
Nakano, Takashi .
JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) :353-358
[28]   Immunohistochemical staining of DNA topoisomerase IIα in human gliomas [J].
Taniguchi, K ;
Wakabayashi, T ;
Yoshida, T ;
Mizuno, M ;
Yoshikawa, K ;
Kikuchi, A ;
Nakashima, N ;
Yoshida, J .
JOURNAL OF NEUROSURGERY, 1999, 91 (03) :477-482
[29]   Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index [J].
Uematsu, M ;
Ohsawa, I ;
Aokage, T ;
Nishimaki, K ;
Matsumoto, K ;
Takahashi, H ;
Asoh, S ;
Teramoto, A ;
Ohta, S .
JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (03) :231-238
[30]   Cenp-F (mitosin) is more than a mitotic marker [J].
Varis, Asta ;
Salmela, Anna-Leena ;
Kallio, Marko J. .
CHROMOSOMA, 2006, 115 (04) :288-295